Total Equity - Eliem Therapeutics Inc (NASDAQ:ELYM) - Alpha Spread

Eliem Therapeutics Inc
NASDAQ:ELYM

Watchlist Manager
Eliem Therapeutics Inc Logo
Eliem Therapeutics Inc
NASDAQ:ELYM
Watchlist
Price: 8.43 USD 1.81% Market Closed
Market Cap: 563m USD
Have any thoughts about
Eliem Therapeutics Inc?
Write Note

Eliem Therapeutics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Eliem Therapeutics Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Eliem Therapeutics Inc
NASDAQ:ELYM
Total Equity
$107.6m
CAGR 3-Years
71%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6.8B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.3B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Total Equity
$5.9B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
-13%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$14.8B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$28.2B
CAGR 3-Years
23%
CAGR 5-Years
24%
CAGR 10-Years
28%

See Also

What is Eliem Therapeutics Inc's Total Equity?
Total Equity
107.6m USD

Based on the financial report for Dec 31, 2023, Eliem Therapeutics Inc's Total Equity amounts to 107.6m USD.

What is Eliem Therapeutics Inc's Total Equity growth rate?
Total Equity CAGR 3Y
71%

Over the last year, the Total Equity growth was -16%. The average annual Total Equity growth rates for Eliem Therapeutics Inc have been 71% over the past three years .

Back to Top